SWK HoldingsSWKH
About: SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment.
Employees: 26
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
19% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 16
9% more capital invested
Capital invested by funds: $170M [Q4 2024] → $186M (+$16M) [Q1 2025]
0% more funds holding
Funds holding: 52 [Q4 2024] → 52 (+0) [Q1 2025]
0% more funds holding in top 10
Funds holding in top 10: 2 [Q4 2024] → 2 (+0) [Q1 2025]
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
0.31% less ownership
Funds ownership: 87.56% [Q4 2024] → 87.25% (-0.31%) [Q1 2025]
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
1 analyst rating
Maxim Group Michael Diana | 26%upside $18 | Buy Maintained | 19 May 2025 |
Financial journalist opinion









